Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.

Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms. Tumori. 2017 Jul 31; 103(4):325-337.

View in: PubMed

subject areas

Acrylamides
Aniline Compounds
Carcinoma, Non-Small-Cell Lung
Disease Progression
Drug Resistance, Neoplasm
ErbB Receptors
Erlotinib Hydrochloride
Humans
Mutation
Piperazines
Protein Kinase Inhibitors
Quinazolines

authors with profiles

Marina Chiara Garassino